Marker Therapeutics
MRKR
MRKR
6 hedge funds and large institutions have $75K invested in Marker Therapeutics in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 0 reducing their positions, and 3 closing their positions.
Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
BlackRock
New York
|
$57K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$8K |
Top Sellers
| 1 |
VKH
1
Virtu KCG Holdings
New York
|
$0 |
| 2 |
2
Millennium Management
New York
|
$0 |
| 3 |
3
Goldman Sachs
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
BlackRock
New York
| $57K | 14,626 | +14,626 | New |
|
|
NSIM
2
North Star Investment Management
Chicago,
Illinois
| $9K | 2,230 | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $8K | 2,013 | +2,013 | New |
|
|
AG
4
Advisor Group
Phoenix,
Arizona
| $1K | 279 | – | – |
|
|
VKH
5
Virtu KCG Holdings
New York
| – | – | -12,110 | Closed |
|
|
6
Millennium Management
New York
| – | – | -11,034 | Closed |
|
|
7
Goldman Sachs
New York
| – | – | -10,593 | Closed |
|
8
Morgan Stanley
New York
| $0 | 12 | – | – |
|
9
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $0 | 1 | – | – |
|